Overview

Sublingual Immunotherapy Studies for Grass and Dust Mite Allergies

Status:
Completed
Trial end date:
2014-01-01
Target enrollment:
Participant gender:
Summary
This is a study for children and adults who are interested in a new therapy for their allergies to dust mite and timothy grass. The new therapy is called sublingual immunotherapy and the investigators are testing if it is safe and well tolerated.
Phase:
Phase 1
Details
Lead Sponsor:
Stanford University
Treatments:
Immunologic Factors